Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus

Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus

Respiratory syncytial virus (RSV) is the most common cause of respiratory tract infections in both children and elderly people. In this study we evaluated the short- and long-term protective efficacy of a single intranasal (IN) immunization with a RSV vaccine formulation consisting of a codon-optimi...

Full description

Bibliographic Details
Main Authors: R. Garg, L. Latimer, V. Gerdts, A. Potter, S. van Drunen Littel-van den Hurk
Format: Article
Language:English
Published: Taylor & Francis Group 2017-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
adjuvant
mucosal immunity
protection
rsv
subunit vaccine
Online Access:http://dx.doi.org/10.1080/21645515.2017.1349584

Similar Items

Similar Items